225 related articles for article (PubMed ID: 3329113)
1. Tenoxicam or diclofenac in the treatment of gonarthrosis.
Chahade WH; Marques GC
Eur J Rheumatol Inflamm; 1987; 9(2):77-80. PubMed ID: 3329113
[No Abstract] [Full Text] [Related]
2. Clinical, double-blind long-term study of tenoxicam 20 mg (Ro 12-0068) versus piroxicam 20 mg in patients with gonarthrosis.
Battagliotti CA; Baetti EA
Eur J Rheumatol Inflamm; 1987; 9(2):74-6. PubMed ID: 3329112
[No Abstract] [Full Text] [Related]
3. A long-term, double-blind, comparative study of tenoxicam (Ro 12-0068) and piroxicam in gonarthrosis and coxarthrosis.
Orozco-Alcalá JJ; Barrera-Tenorio EF
Eur J Rheumatol Inflamm; 1987; 9(2):109-13. PubMed ID: 3329100
[No Abstract] [Full Text] [Related]
4. Long-term study with tenoxicam (Ro 12-0068) in the treatment of gonarthrosis and coxarthrosis.
Rubinstein J; Sidi A
Eur J Rheumatol Inflamm; 1987; 9(2):126-8. PubMed ID: 3329104
[No Abstract] [Full Text] [Related]
5. A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.
Bellamy N; Buchanan WW; Chalmers A; Ford PM; Kean WF; Kraag GR; Gerecz-Simon E; Campbell J
J Rheumatol; 1993 Jun; 20(6):999-1004. PubMed ID: 8350339
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experiences with tenoxicam. Preliminary results of a multicenter study].
Marcolongo R; Fioravanti A
Recenti Prog Med; 1991 Apr; 82(4):242-9. PubMed ID: 1857847
[TBL] [Abstract][Full Text] [Related]
7. A comparison of tenoxicam and piroxicam in a long-term clinical study in patients with osteoarthritis of hip or knee joints.
Waterworth RF; Waterworth SM; Taylor KM
Eur J Rheumatol Inflamm; 1985; 8(1):21-7. PubMed ID: 3915884
[No Abstract] [Full Text] [Related]
8. A double-blind randomised multicentre study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulant patients with osteoarthritis and extra-articular rheumatism.
Moser U; Waldburger H; Schwarz HA; Gobelet CA
Scand J Rheumatol Suppl; 1989; 80():71-80. PubMed ID: 2688081
[TBL] [Abstract][Full Text] [Related]
9. A long-term randomised trial on tenoxicam and piroxicam in osteoarthritis of the hip or knee: a 24-month interim report focusing on the 12-24 month interval.
Lund B; Andersen RB; Fossgreen J; Holm P; Jensen EM; Kirchheiner B; Kryger J; Pichard J
Eur J Rheumatol Inflamm; 1987; 9(2):58-67. PubMed ID: 3329110
[TBL] [Abstract][Full Text] [Related]
10. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
Bird HA; Hill J; Dixon JS; Looi D; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism].
Moser U; Waldburger M; Schwarz HA; Gobelet CA
Schweiz Rundsch Med Prax; 1989 Mar; 78(10):263-9. PubMed ID: 2649954
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
Kidd B; Frenzel W
J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
Porzio F
Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
[TBL] [Abstract][Full Text] [Related]
14. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis.
Riedemann PJ; Bersinic S; Cuddy LJ; Torrance GW; Tugwell PX
J Rheumatol; 1993 Dec; 20(12):2095-103. PubMed ID: 8014938
[TBL] [Abstract][Full Text] [Related]
15. Tenoxicam compared with diclofenac in patients with ankylosing spondylitis.
Schwarzer AC; Cohen M; Arnold MH; Kelly D; McNaught P; Brooks PM
Curr Med Res Opin; 1990; 11(10):648-53. PubMed ID: 2178870
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
Astorga G
Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111
[No Abstract] [Full Text] [Related]
17. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
Havranek H
Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
[No Abstract] [Full Text] [Related]
18. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
Perpignano G; Bogliolo A; Puccetti L
Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
[TBL] [Abstract][Full Text] [Related]
19. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis.
Gentiletti AA
Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116
[No Abstract] [Full Text] [Related]
20. Tenoxicam (Ro 12-0068) in patients with extra-articular rheumatism.
Orozco-Alcalá JJ; Barrera-Tenorio EF
Eur J Rheumatol Inflamm; 1987; 9(2):114-7. PubMed ID: 3329101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
